Summary
The results of a subanalysis of data from ARISTOTLE, demonstrated that the benefit of apixaban over warfarin was not related to the quality of INR control at the individual ARISTOTLE study centers.
- Cardiology Clinical Trials
- Cerebrovascular Disease
- Arrhythmias
- © 2011 MD Conference Express